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IL-4 wasinitiallydescribed as a co-stimulant of DNA synthesis forB lymphocytes
stimulated with anti-IgM antibody (1). Since then, many effects of IL-4 on various
hematological cell types have been reported (for review see reference 2).
The effects of IL-4 on hematopoiesis have not been studied extensively. On both
murine (3, 4) and human (5)bone marrow cells, enhancement oferythroid colony
growth by IL-4 in thepresence of erythropoietin (EPO) has been reported. In addi-
tion, IL-4 enhances granulocytecolony-stimulating factor (G-CSF)-induced granulo-
cytic colony formation (3-5).
In the present study we describe the effects of human rIL-4 on hematopoiesis in
vitro. We show a marked, dose-dependent reduction ofmacrophage colony forma-
" (CFU-M) after addition of IL-4 to bone marrow progenitors stimulated with
either granulocyte/macrophage CSF (GM-CSF) or macrophage CSF (M-CSF).
Materials and Methods
IL-4.
￿
HumanrIL-4 was kindly provided by Dr. P Herman andDr. P P Trotta, Schering
Corp., Bloomfield, NJ. HumanIL-4 c-DNAwasexpressedin Chinesehamsterovary (CHO)
cells andthe produced (glycosilated) protein was purified (>95% pure). Forcontrol experi-
ments, a second IL-4 preparation was used (Genzyme, Boston, MA). The c-DNA for this
IL-4 was expressed in yeast, enzymatically deglycosilated, and purified (>95% pure). This
protein had a specific activity of 108 U/mg, 1 unit being defined as half-maximal stimula-
tion in a B cell proliferation assay.
Anti-IL-4Antiserum.
￿
Anti-IL-4antiserum, akind gift ofDr. J. E. de Vries, (Unicet, Dardilly,
France) was raised in a rabbit against human rIL-4. This anti-IL-4 antiserum blocked the
biological activity of IL-4 as measured in both a B and a T cell proliferation assay.
Cell Reparations.
￿
Bone marrow mononuclear cells were obtained after informed consent
from donors for allogeneic bone marrow transplantation or from hernia nuclei pulposi pa-
who underwentlaminectomy. Light density bone marrow cells were isolated by Ficoll
Isopaque (1.077 g/cms) density gradient centrifugation. If necessary, the cells were depleted
of monocytes by carbonyl iron incorporation and a magnetic stirrer, and they were T
cell-depleted by rosetting with 2-aminoethylisothiouronium hydrobromide-treated sheep
erythrocytes followed by Ficoll separation (6, 7). These depleted bone marrow suspensions
contained <1% monocytes, as determined by a-naphthyl acetate esterase (ANAE) staining
and <1% T cells as determined by staining with anti-CD3 mAb (anti-Leu-4; Becton Dick-
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inson & Co., Mountain View, CA) and goat anti-mouse FITC (GAM-FITC; CLB, Am-
sterdam, The Netherlands).
For some experiments, bone marrow cells were enriched for progenitor cells using mAbs
against the CD34 and HLA-DR antigens, followed by FAGS. Monocyte- and T cell-depleted
lightdensity bone marrow cells (2.5 x 106 cells/ml) were preincubated with 5% rabbit serum
to prevent nonspecific Fc binding followed by incubation with 20 jug/ml anti-CD34 (MY10)
mAb (Becton Dickinson & Co.). Cells were labeled with GAM-FITC (6 lLg/ml) and incubated
with Iscove's modified Dulbeccds medium (IMDM) containing 50% mouse serum in order
to block nonspecific binding of the subsequent antibodies. Next, cells were incubated with
1.3 p,g/ml anti-HLA-DR antibody conjugated to phycoerythrin (Becton Dickinson & Co.).
CD34*HLA-DR' cells were sorted using a FACStar (argon-ion laser tuned at 488 nm,
Becton Dickinson & Co.). From the HLA-DR' cells, presenting as a separate cluster, the
CD34' cells were isolated. The cut-off point was chosen after the first log decade, based on
the fluorescence intensity of a control sample stained with the GAM-FITC-labeled antibody
only.
BFU-E Cultures.
￿
Bone marrow progenitor cells were cultured as described (6, 7). Light
density bone marrow cells were cultured at a concentration of 105/ml in IMDM containing
20% FCS, 5 x 10-5 M 2-ME, 0.5 g/liter deionized BSA, 0.47 g/liter human transferrin
(Behringwerke AG, Marburg, Federal Republic of Germany), 10-5 FeC13-6H20, and 0.98%
methylcellulose (Methocel, Oud Beyerland, The Netherlands). Colony formation was stimu-
lated with purified human EPO (1 U/ml; kindly provided by Organon Teknika BV, Turn-
hout, Belgium) and either human rGM-CSF (50 U/ml; a gift ofthe Schering Corp.), or human
rM-CSF (a gift of Dr. P Ralph; Cetus Corp., Emeryville, CA). 100,ul/well was plated in
sixfold in flat-bottomed microtiter plates (Greiner, Alphen a/d Rijn, The Netherlands). Growth
of the relatively mature erythroid colony forming units (CFU-E, compact clusters of 8-64
erythroid cells) was scored on day 7 . The more immature erythroid burst formingunits (BFU-
E), granulocyte colony forming units (CFU-G, clusters of >50 granulocytis) and CFU-M
(clusters of >20 macrophages) were scored on day 14.
CFU-GM Cultures.
￿
Monocyte- and T cell-depleted light density bone marrow cells were
cultured at a concentration of 0.5 x 105 cells/ml. CD34'HLA-DR' cells were cultured at
a concentration of 104 cells/ml. Cells were cultured in a-MEM containing 207o FCS and
0.96% methylcellulose. Colony growth was stimulated with 50 U/ml human rGM-CSF. 100
pl/well was plated in sixfold in flat-bottomed microtiter plates. CFU-G and CFU-M colonies
were scored on day 14.
Cultures were kept in a fully humidified 5% C02 atmosphere at 37°C. After the culture
period, colonies were scored with an inverted microscope and, in some experiments, mass-
harvested or picked individually with a micropipette, spread on microscope slides, and stained
with ANAE or May-Grunwald Giemsa to confirm the monocytic or granulocytic lineage.
Results
Light Density Bone Marrow Cells.
￿
To study the influence of IL-4 on colony forma-
tion by human bone marrow progenitor cells, we added increasing concentrations
of human HL-4 to cultures oflight density bone marrow cellsstimulated with human
rGM-CSF and EPO. A dose-dependent inhibition of macrophage colony formation
was observed in bone marrow cultures offive successive donors (Fig. 1). At a concen-
tration of 5 ng IL-4/ml, macrophage colony growth was reduced to ± 20% of con-
trol values. In contrast, erythroid (CFU-E and BFU-E) and granulocytic colony growth
were not affected by IL-4.
Role ofAccessory Cells.
￿
To study whether the IL-4-dependent inhibition of macro-
phage colony growth was mediated by accessory cell populations, we cultured
monocyte- and T cell-depleted light density bone marrow cellsstimulated with GM-
CSR Again, IL-4 induced a dose-dependent inhibitionofmacrophage colony forma-
tion (Fig. 2 A), suggesting that the effect was exerted directly on the hematopoietic160
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FIGURE 1.
￿
InfluenceofIL-4 on colony formationbylightdensity bone marrow cellsstimulated
with GM-CSF (50 U/ml) and EPO (1 U/ml). Data are expressed as percentage (mean t SD,
n = 5) of the number of colonies obtained in control cultures (without IL-4 added). In these
cultures, mean control growth was 106 CFU-E, 104 BFU-E, 76 CFU-G, and 55 CFU-M colo-
nies/105 cells.
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FIGURE 2.
￿
Influence of IL-4 on colony formation by (A) monocyte/T cell-depleted (n = 5,
mean t SD) and (B) CD34'/HLA-DR'-enriched bone marrow cells stimulated with GM-CSF
(50U/ml). Data are expressedas percentage ofthe number of colonies obtained in control cul-
tures(without IL-4 added). In themonocyte/T cell-depleted cultures, mean control growth was
100 CFU-G and 269 CFU-M colonies/105 cells. Control growth in the CD34'/HLA-DR' cul-
tures was 2,483 CFU-G and 3,950 CFU-M colonies/105 cells.580
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progenitor cells. To furtherexplore this, we cultured FAGS-sorted CD34+HLA-DR'
cells stimulated with GM-CSF. A similar dose-dependent inhibition of macrophage
colony formation by IL-4 was found, whereas granulocytic colony numbers were
not reduced (Fig. 2 B) .
ControlExperiments.
￿
To confirm that the observed inhibition was due to IL-4 and
not to a toxic contamination, we performed the following control experiments.
IL-4 was heat inactivated (20 min at 100°C) and added to the cultures at a con-
centration of 50 ng/ml. In all experiments (n = 8) the IL-4-induced inhibition of
CFU-M was completely abrogated (data not shown).
Human rIL-4 from another source, a nonglycosilated protein, was tested on
monocyte- and T cell-depleted bone marrow cells. This IL-4 had a similar inhibi-
tory effect on CFU-M growth (inhibition up to 9070) as the recombinant human
glycosilated IL-4 preparation, at the same concentration of IL-4 as measured in an
ELISA, courtesy of Dr. J. E. de Vries (data not shown).
IL-4 was preincubated (1 h at 37°C) with increasing concentrations of anti-IL-4
antiserum. The observed effect on CFU-M colony growth could be completely
abrogated by this antiserum in a dose-dependent fashion (Fig. 3).
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FIGURE 3 .
￿
Effect ofanti-IL-4 antise-
rum on inhibition of CFU-M colony
formation by IL-4. Monocyte- and T
cell-depleted bone marrow cells were
cultured with GM-CSF(50 U/ml). The
number of CFU-M colonies/105 cells
is shown. Control CFU-M growth (cul-
ture without IL-4 added) was 513/105
cells.
FIGURE 4.
￿
Influence of IL-4 on macrophage colony forma-
tion by monocyte- and T cell-depleted bone marrow cells, in-
duced with EPO (1 U/ml) and M-CSF (1,000 U/ml). The
number of CFU-M colonies/105 cells is shown.JANSEN ET AL.
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M-CSF-stimulated Colony Formation.
￿
To study whether the inhibition of macro-
phage colony formation by IL-4 was dependent on the growth factor used to induce
colony growth, increasing doses of IL-4 were added to monocyte- andT cell-depleted
bone marrow cultures in which colony growth was induced with EPO and M-CSF.
These experiments yielded a similar dose-dependent inhibition of CFU-M growth
as observed in GM-CSF-induced cultures (Fig. 4).
Discussion
In this article we studied the influence of IL-4 on colony formation by bone
marrow-derived hematopoietic progenitor cells. We observed that colony formation
by monocytic precursor cells (CFU-M) was inhibited in a dose-dependent fashion,
whereas colony growth of other lineages was not affected. Concentrations of 0.5 ng
IL-4/ml were able to reduce CFU-M growth and profound inhibition was obtained
at concentrations higher than 5 ng IL-4/ml.
Inhibition was stillseen when asecond, nonglycosilated IL-4 preparation wasused
and could be abrogated by heat inactivation or incubation of the IL-4 with a neu-
tralizing anti-IL-4-antiserum, confirming that this inhibition was due to IL-4 and
not to some nonspecific toxic contamination .
The IL-4-induced inhibition of macrophage colony formation was not only seen
in cultures oflight densityandcultures ofmonocyte- and Tcell-depleted bone marrow
cells but was still observed on bone marrow cell suspensions enriched ( t 50-fold
compared with light density bone marrow cells) for CD34+ HLA-DR' progenitor
cells(Fig. 2). These resultssuggest a direct effect ofIL-4 on monocyticprogenitor cells.
The effect of IL-4 on CFU-M growth was not restricted to GM-CSF-stimulated
colony growth, but was also observed in M-CSF-stimulated bone marrow cultures.
Since colony growth of other lineages was not affected, these findings indicate that
inhibition wasnot caused by interference of IL-4 with thereceptors forcolony-stimu-
lating factors. We speculate that IL-4, in addition to possible synergism with growth
factors such as EPO and G-CSF (3-5), acts directly on hematopoietic progenitor
cells by either committing them to nonmonocytic lineages or by blocking theprolifer-
ation ofmonocyte-committed progenitor cells. We favor the latter hypothesis, since
inhibition of CFU-M was not accompanied by a compensatory increase in colony
formation of other lineages of differentiation. This might well correlate with data
from others, describing IL-4-induced differentiation ofmononuclearphagocytes (8-11).
In conclusion, we describe an IL-4-induced, specific inhibition of macrophage
colony formation by bone marrow cells that appears to be exerted directly on the
bone marrow progenitor cells. In addition to the production oflineage-specific growth
factors, these results imply a mechanism by which hematopoiesis might be regu-
lated in alineage-specific fashion. To what extent this represents aphysiological function
of IL-4 remains to be elucidated.
Summary
We investigated the effects ofhuman rIL-4 on in vitrohematopoiesis. Aprofound
inhibition of macrophage colony formation by IL-4 was observed, whereas colony
growth of other lineages was not affected. Inhibition of macrophage colony growth
was not restricted to GM-CSF-induced colony growth but was also present in cul-582
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tures stimulated with M-CSR This inhibition was not only observed in cultures of
light density bone marrow cells, but also in cultures ofmonocyte- and T lymphocyte-
depleted bone marrow cells. Since a similar inhibition was observed in cultures of
CD34''HLA-DR'-enriched bone marrow cells, a direct action of IL-4 on mono-
cyte-committed progenitor cells is suggested.
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(Schering Corp.) for providing the rIL-4 .
Receivedfor publication 4 April 1989 and in revisedform 22 May 1989.
References
1 . Howard, M., J. Farrar, M. Hilfiker, B. Johnson, K. Takatsu, T Hamaoka, and W E.
Paul. 1982. Identification ofa T-cell derived B cell growth factor distinct from interleukin
2. j. Exp. Med. 155:914.
2 . Paul, W. E., and J . Ohara. 1987. B-cell stimulatory factor-1/Interleukin 4. Annu. Rev.
Immunol. 5:429.
3 . Peschel, C., W E. Paul,J. Ohara, and I. Green. 1987. Effects ofB cell stimulatory factor-
1Jinterleukin 4 on hematopoietic progenitor cells. Blood. 70:254.
4. Rennick, D., G. Yang, C. Muller-Sieburg, C. Smith, N. Arai, Y. Takabe, and L. Gem-
mell. 1987. Interleukin 4 (B-cell stimulatory factor 1) can enhance or antagonize the factor-
dependent growth ofhematopoietic progenitor cells. Proc. Nad. Acad Sci. USA. 84:6889.
5 . Broxmeyer, H. E., L. Lu, S. Cooper, R. Tushinski, D. Mochizuki, B. Y Rubin, S. Gillis,
and D. E. Williams. 1988. Synergistic effects ofpurified recombinant human and murine
B cell growth factor-l/IL-4 on colony formation in vitro by hematopoietic progenitor
cells. l Immunol. 141:3852.
6. Fibbe, W. E., J. van Damme, A. Billiau, P J. Voogt, N. Duinkerken, I? M. C. Muck,
andJ. H. Falkenburg. 1986. Interleukin-1 (22-K factor) induces release of granulocyte-
macrophage colony-stimulating activity from human mononuclear phagocytes. Blood .
68:1316.
7 . Kluin-Nelemans, J. C., H. W. J. Hakvoort, J. H. Jansen, N. Duinkerken, J. F van den
Burg, J. H. Falkenburg, and R. Willemze. 1988. Colony growth of normal and neo-
plastic cells in various concentrations of methylcellulose. Exp. Hematol. 16:922.
8. Vercelli, D., H. H. Jabara, B. Lee, N. Woodland, R. S. Geha, and D. Y. M. Leung.
1988. Human recombinant interleukin 4 induces FceR2/CD23 on normal human mono-
cytes. J Exp. Med. 167:1406.
9 . Stuart, P. M ., A. Zlotnik, andJ. G. Woodward. 1988. Induction of class I and class II
MHC antigen expression on murine bone marrow-derived macrophages by IL-4 (B cell
stimulatory factor 1). j. Immunol. 140:1542.
10 . Te Velde, A. A., J. P G. Klomp, B. A. Yard, J. E. de Vries, and C. G. Figdor. 1988.
Modulation of phenotypic and functional properties of human peripheral blood mono-
cytes by IL-4. ,j Immunol. 140:1548.
11 . McInnes, A., and D. M. Rennick. 1988. Interleukin 4 induces cultured monocyteslmac-
rophages to form giant multinucleated cells. ,j. Exp. Med. 167:598.